Article
Discovery of agents that eradicate leukemia stem cells using an in silico screen of public gene expression data
27 Feb 2008
Abstract excerpt
Increasing evidence indicates that malignant stem cells are important for the pathogenesis of acute myelogenous leukemia (AML) and represent a reservoir of cells that drive the development of AML and relapse. Therefore, new treatment regimens are necessary to prevent relapse and improve therapeutic outcomes. Previous studies have shown that the sesquiterpene lactone, parthenolide (PTL), ablates bulk, progenitor,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
